Detailed information for compound 61876

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 442.556 | Formula: C26H30N6O
  • H donors: 1 H acceptors: 4 LogP: 3.88 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCC1=NC2(CCCC2)CC(=O)N1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1
  • InChi: 1S/C26H30N6O/c1-2-3-10-23-27-26(15-6-7-16-26)17-24(33)32(23)18-19-11-13-20(14-12-19)21-8-4-5-9-22(21)25-28-30-31-29-25/h4-5,8-9,11-14H,2-3,6-7,10,15-18H2,1H3,(H,28,29,30,31)
  • InChiKey: QQXUWSWJFJDVQE-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Type-1B angiotensin II receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus multilocularis neuropeptide receptor Type-1B angiotensin II receptor   359 aa 317 aa 24.9 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 305 aa 24.9 %
Echinococcus granulosus neuropeptide receptor Type-1B angiotensin II receptor   359 aa 317 aa 24.6 %
Loa Loa (eye worm) hypothetical protein Type-1B angiotensin II receptor   359 aa 308 aa 27.6 %
Echinococcus granulosus allatostatin A receptor Type-1B angiotensin II receptor   359 aa 342 aa 27.2 %
Schistosoma mansoni peptide (FMRFamide/somatostatin)-like receptor Type-1B angiotensin II receptor   359 aa 346 aa 18.2 %
Echinococcus multilocularis G-protein coupled receptor, putative Type-1B angiotensin II receptor   359 aa 307 aa 22.1 %
Schistosoma mansoni peptide (allatostatin)-like receptor Type-1B angiotensin II receptor   359 aa 323 aa 25.7 %
Loa Loa (eye worm) hypothetical protein Type-1B angiotensin II receptor   359 aa 329 aa 24.0 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 355 aa 23.9 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 386 aa 24.4 %
Brugia malayi putative neuropeptide receptor NPR1 Type-1B angiotensin II receptor   359 aa 295 aa 27.1 %
Schistosoma mansoni biogenic amine (octopamine/dopamine) receptor Type-1B angiotensin II receptor   359 aa 350 aa 23.1 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Type-1B angiotensin II receptor   359 aa 363 aa 23.4 %
Schistosoma mansoni opsin-like receptor Type-1B angiotensin II receptor   359 aa 299 aa 25.8 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Type-1B angiotensin II receptor   359 aa 307 aa 24.1 %
Echinococcus granulosus growth hormone secretagogue receptor type 1 Type-1B angiotensin II receptor   359 aa 343 aa 23.0 %
Loa Loa (eye worm) neuropeptide F receptor Type-1B angiotensin II receptor   359 aa 344 aa 23.5 %
Echinococcus multilocularis pyroglutamylated rfamide peptide receptor Type-1B angiotensin II receptor   359 aa 365 aa 20.0 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 292 aa 24.7 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 350 aa 24.0 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 309 aa 18.8 %
Echinococcus granulosus pyroglutamylated rfamide peptide receptor Type-1B angiotensin II receptor   359 aa 366 aa 19.7 %
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily Type-1B angiotensin II receptor   359 aa 300 aa 21.0 %
Echinococcus multilocularis allatostatin A receptor Type-1B angiotensin II receptor   359 aa 342 aa 26.6 %
Onchocerca volvulus E3 ubiquitin-protein ligase rpm-1 homolog Type-1B angiotensin II receptor   359 aa 354 aa 20.6 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Type-1B angiotensin II receptor   359 aa 325 aa 20.9 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 314 aa 25.2 %
Echinococcus granulosus tm gpcr rhodopsin Type-1B angiotensin II receptor   359 aa 300 aa 21.0 %
Echinococcus granulosus thyrotropin releasing hormone receptor Type-1B angiotensin II receptor   359 aa 363 aa 23.7 %
Brugia malayi GnHR receptor homolog Type-1B angiotensin II receptor   359 aa 357 aa 20.4 %
Brugia malayi ORL1-like opioid receptor Type-1B angiotensin II receptor   359 aa 314 aa 20.4 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Carboxylesterase family protein 0.1858 1 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.1858 1 1
Echinococcus granulosus neuroligin 0.0314 0.1485 0.1485
Loa Loa (eye worm) carboxylesterase 0.1858 1 1
Mycobacterium tuberculosis Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) 0.0589 0.3001 1
Echinococcus multilocularis acetylcholinesterase 0.1858 1 1
Echinococcus multilocularis BC026374 protein (S09 family) 0.0314 0.1485 0.1485
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0314 0.1485 0.1485
Plasmodium falciparum thioredoxin reductase 0.0074 0.0162 1
Trypanosoma cruzi trypanothione reductase, putative 0.0074 0.0162 1
Brugia malayi Carboxylesterase family protein 0.0314 0.1485 0.1485
Brugia malayi Carboxylesterase family protein 0.0314 0.1485 0.1485
Loa Loa (eye worm) hypothetical protein 0.0314 0.1485 0.1485
Leishmania major trypanothione reductase 0.0074 0.0162 1
Loa Loa (eye worm) hypothetical protein 0.0314 0.1485 0.1485
Schistosoma mansoni BC026374 protein (S09 family) 0.0314 0.1485 0.1485
Echinococcus granulosus carboxylesterase 5A 0.1858 1 1
Brugia malayi Carboxylesterase family protein 0.0314 0.1485 0.1485
Loa Loa (eye worm) hypothetical protein 0.0314 0.1485 0.1485
Mycobacterium tuberculosis Carboxylesterase LipT 0.0314 0.1485 0.4949
Onchocerca volvulus 0.0314 0.1485 1
Loa Loa (eye worm) hypothetical protein 0.0314 0.1485 0.1485
Echinococcus multilocularis neuroligin 0.0314 0.1485 0.1485
Onchocerca volvulus 0.0314 0.1485 1
Chlamydia trachomatis protoporphyrinogen oxidase 0.0045 0 0.5
Loa Loa (eye worm) acetylcholinesterase 1 0.1858 1 1
Plasmodium falciparum glutathione reductase 0.0074 0.0162 1
Echinococcus multilocularis acetylcholinesterase 0.1858 1 1
Brugia malayi Carboxylesterase family protein 0.0314 0.1485 0.1485
Echinococcus granulosus BC026374 protein S09 family 0.0314 0.1485 0.1485
Onchocerca volvulus 0.0314 0.1485 1
Onchocerca volvulus 0.0314 0.1485 1
Loa Loa (eye worm) hypothetical protein 0.0314 0.1485 0.1485
Brugia malayi glutathione reductase 0.0074 0.0162 0.0162
Loa Loa (eye worm) hypothetical protein 0.1858 1 1
Loa Loa (eye worm) carboxylesterase 0.0314 0.1485 0.1485
Echinococcus granulosus thioredoxin glutathione reductase 0.0074 0.0162 0.0162
Echinococcus multilocularis carboxylesterase 5A 0.1858 1 1
Echinococcus granulosus para nitrobenzyl esterase 0.0314 0.1485 0.1485
Mycobacterium leprae PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) 0.0045 0 0.5
Echinococcus multilocularis para nitrobenzyl esterase 0.0314 0.1485 0.1485
Loa Loa (eye worm) carboxylesterase 0.0314 0.1485 0.1485
Mycobacterium ulcerans carboxylesterase, LipT 0.0314 0.1485 0.4574
Plasmodium vivax thioredoxin reductase, putative 0.0074 0.0162 1
Echinococcus granulosus acetylcholinesterase 0.1858 1 1
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0314 0.1485 0.5
Schistosoma mansoni neuroligin 3 (S09 family) 0.0314 0.1485 0.1485
Plasmodium vivax glutathione reductase, putative 0.0074 0.0162 1
Trypanosoma brucei trypanothione reductase 0.0074 0.0162 0.5
Brugia malayi Thioredoxin reductase 0.0074 0.0162 0.0162
Echinococcus granulosus acetylcholinesterase 0.1858 1 1
Echinococcus granulosus family S9 non peptidase ue S09 family 0.0314 0.1485 0.1485
Loa Loa (eye worm) glutathione reductase 0.0074 0.0162 0.0162
Loa Loa (eye worm) thioredoxin reductase 0.0074 0.0162 0.0162
Trichomonas vaginalis spcc417.12 protein, putative 0.0314 0.1485 0.5
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0314 0.1485 0.4949
Brugia malayi hypothetical protein 0.0314 0.1485 0.1485
Schistosoma mansoni gliotactin 0.0314 0.1485 0.1485
Loa Loa (eye worm) hypothetical protein 0.1858 1 1
Toxoplasma gondii thioredoxin reductase 0.0074 0.0162 1
Onchocerca volvulus 0.0314 0.1485 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0314 0.1485 0.1485
Loa Loa (eye worm) hypothetical protein 0.0314 0.1485 0.1485
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH 0.0633 0.3247 1
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0314 0.1485 0.4949
Schistosoma mansoni acetylcholinesterase 0.0314 0.1485 0.1485
Echinococcus multilocularis thioredoxin glutathione reductase 0.0074 0.0162 0.0162
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0314 0.1485 0.1485
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0074 0.0162 0.0539
Loa Loa (eye worm) hypothetical protein 0.0314 0.1485 0.1485
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH 0.0633 0.3247 1
Echinococcus multilocularis family S9 non peptidase ue (S09 family) 0.0314 0.1485 0.1485

Activities

Activity type Activity value Assay description Source Reference
Delta MAP (functional) ~ 10 mmHg Tested for induced pressor response to AII (40 ng/kg, iv) in conscious normotensive rats at a compound dose of 3 mg/kg po for 15 min ChEMBL. No reference
Delta MAP (functional) ~ 14 mmHg Tested for induced pressor response to AII (40 ng/kg, iv) in conscious normotensive rats at a compound dose of 3 mg/kg po for 60 min ChEMBL. No reference
Delta MAP (functional) ~ 15 mmHg Tested for induced pressor response to AII (40 ng/kg, iv) in conscious normotensive rats at a compound dose of 3 mg/kg po for 30 min ChEMBL. No reference
Delta MAP (functional) ~ 15 mmHg Tested for induced pressor response to AII (40 ng/kg, iv) in conscious normotensive rats at a compound dose of 3 mg/kg po for 120 min ChEMBL. No reference
Delta MAP (functional) ~ 17 mmHg Tested for induced pressor response to AII (40 ng/kg, iv) in conscious normotensive rats at a compound dose of 3 mg/kg po for 180 min ChEMBL. No reference
Delta MAP (functional) ~ 18 mmHg Tested for induced pressor response to AII (40 ng/kg, iv) in conscious normotensive rats at a compound dose of 3 mg/kg po for 90 min ChEMBL. No reference
Delta MAP (functional) ~ 27 mmHg Tested for induced pressor response to AII (100 ng/kg, iv) in conscious normotensive monkey at a compound dose of 3 mg/kg po for 1 hr ChEMBL. No reference
Delta MAP (functional) ~ 29 mmHg Tested for induced pressor response to AII (100 ng/kg, iv) in conscious normotensive monkey at a compound dose of 3 mg/kg po for 2 hr ChEMBL. No reference
Delta MAP (functional) ~ 29 mmHg Tested for induced pressor response to AII (100 ng/kg, iv) in conscious normotensive monkey at a compound dose of 3 mg/kg po for 3 hr ChEMBL. No reference
Delta MAP (functional) ~ 32 mmHg Tested for induced pressor response to AII (100 ng/kg, iv) in conscious normotensive monkey at a compound dose of 3 mg/kg po for 4 hr ChEMBL. No reference
Delta MAP (functional) ~ 33 mmHg Tested for induced pressor response to AII (100 ng/kg, iv) in conscious normotensive monkey at a compound dose of 3 mg/kg po for 0 hr ChEMBL. No reference
Delta MAP (functional) ~ 35 mmHg Tested for induced pressor response to AII (40 ng/kg, iv) in conscious normotensive rats at a compound dose of 3 mg/kg po for 0 min ChEMBL. No reference
IC50 (binding) = 1 nM In vitro inhibition of specific binding of [125I]-AII to Angiotensin II receptor, type 1 from rat liver membrane ChEMBL. No reference
IC50 (binding) = 1 nM In vitro inhibition of specific binding of [125I]-AII to Angiotensin II receptor, type 1 from rat liver membrane ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.